Clinical trial
Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk
NCT00814723 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk
- Lead sponsor
- Medical University of Graz
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- September 30, 2007
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.